APA (7th ed.) Citation

Guo R, Liao H, Meng Y, Shi X, He Y, Zhu Z, & Guo W. (2024). Fostamatinib, a Spleen Tyrosine Kinase Inhibitor, Exerts Anti-Inflammatory Activity via Inhibiting STAT1/3 Signaling Pathways. Dove Medical Press.

Chicago Style (17th ed.) Citation

Guo R, Liao H, Meng Y, Shi X, He Y, Zhu Z, and Guo W. Fostamatinib, a Spleen Tyrosine Kinase Inhibitor, Exerts Anti-Inflammatory Activity via Inhibiting STAT1/3 Signaling Pathways. Dove Medical Press, 2024.

MLA (9th ed.) Citation

Guo R, et al. Fostamatinib, a Spleen Tyrosine Kinase Inhibitor, Exerts Anti-Inflammatory Activity via Inhibiting STAT1/3 Signaling Pathways. Dove Medical Press, 2024.